MedPal AI scales rapidly with AI-Powered digital health platform episode artwork

EPISODE · Apr 8, 2026 · 7 MIN

MedPal AI scales rapidly with AI-Powered digital health platform

from Proactive - Interviews for investors · host Proactive Investors

MedPal AI CEO Jason Drummond joined Steve Darling from Proactive to talk about the rapid growth of the company’s AI-powered healthcare platform and its vision to transform access to primary care. Drummond explained how MedPal AI aggregates data from connected health devices such as Apple Watch, Fitbit, and Oura Ring into a single platform, allowing users to gain real-time health insights. He highlighted the scale of this opportunity, stating, “The estimated 1.3 billion people in the world have a connected health device… the level and the quality of the information they collect in real time is incredible.” The platform combines AI-driven analysis with clinician oversight, enabling triage, diagnosis support, and prescription services. MedPal AI integrates a full end-to-end system, including robotic dispensing and rapid medication delivery, creating what Drummond describes as a “complete digital health platform” and a “health operating system.” The company has scaled strongly since launch, reaching approximately 41,000 prescription orders in a single month and achieving a run rate exceeding £5 million in revenue within just 16 weeks. Drummond emphasized the importance of combining AI with human clinicians to deliver real-world outcomes, including medication and continuous health monitoring. Looking ahead, MedPal AI is focused on expanding its footprint, with Germany recently launched and the US identified as a major future market opportunity. MedPal is a UK-based, AI-driven, closed-loop digital health platform that aggregates data from over 100 wearables/apps to provide personalized wellness insights, clinical consultations, and rapid, robotically dispensed medication delivery. It operates via a smartphone app (iOS/Android) that acts as a personal health command center, aiming to bridge the gap between wellness tracking and proactive medical care. #proactiveinvestors #medpalai #aim #mpal #MedPalAI #DigitalHealth #AIHealthcare #HealthTech #ConnectedDevices #Wearables #Telemedicine #PrescriptionDelivery #HealthPlatform #PatientCare #MedicalInnovation #AIAnalytics #HealthcareAI #GlobalHealth #HealthTechInnovation

MedPal AI CEO Jason Drummond joined Steve Darling from Proactive to talk about the rapid growth of the company’s AI-powered healthcare platform and its vision to transform access to primary care. Drummond explained how MedPal AI aggregates data from connected health devices such as Apple Watch, Fitbit, and Oura Ring into a single platform, allowing users to gain real-time health insights. He highlighted the scale of this opportunity, stating, “The estimated 1.3 billion people in the world have a connected health device… the level and the quality of the information they collect in real time is incredible.” The platform combines AI-driven analysis with clinician oversight, enabling triage, diagnosis support, and prescription services. MedPal AI integrates a full end-to-end system, including robotic dispensing and rapid medication delivery, creating what Drummond describes as a “complete digital health platform” and a “health operating system.” The company has scaled strongly since launch, reaching approximately 41,000 prescription orders in a single month and achieving a run rate exceeding £5 million in revenue within just 16 weeks. Drummond emphasized the importance of combining AI with human clinicians to deliver real-world outcomes, including medication and continuous health monitoring. Looking ahead, MedPal AI is focused on expanding its footprint, with Germany recently launched and the US identified as a major future market opportunity. MedPal is a UK-based, AI-driven, closed-loop digital health platform that aggregates data from over 100 wearables/apps to provide personalized wellness insights, clinical consultations, and rapid, robotically dispensed medication delivery. It operates via a smartphone app (iOS/Android) that acts as a personal health command center, aiming to bridge the gap between wellness tracking and proactive medical care. #proactiveinvestors #medpalai #aim #mpal #MedPalAI #DigitalHealth #AIHealthcare #HealthTech #ConnectedDevices #Wearables #Telemedicine #PrescriptionDelivery #HealthPlatform #PatientCare #MedicalInnovation #AIAnalytics #HealthcareAI #GlobalHealth #HealthTechInnovation

NOW PLAYING

MedPal AI scales rapidly with AI-Powered digital health platform

0:00 7:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Proactive - Interviews for investors?

This episode is 7 minutes long.

When was this Proactive - Interviews for investors episode published?

This episode was published on April 8, 2026.

What is this episode about?

MedPal AI CEO Jason Drummond joined Steve Darling from Proactive to talk about the rapid growth of the company’s AI-powered healthcare platform and its vision to transform access to primary care. Drummond explained how MedPal AI aggregates data...

Can I download this Proactive - Interviews for investors episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!